|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Methyldopa#Contraindications]] |
| {{Methyldopa}}
| |
| {{CMG}}; {{AE}} {{AK}}
| |
| | |
| ==Contraindications==
| |
| | |
| Methyldopate hydrochloride is contraindicated in patients:
| |
| | |
| - with active hepatic disease, such as acute [[hepatitis ]]and active [[cirrhosis]].
| |
| | |
| - with liver disorders previously associated with methyldopa therapy (see [[Methyldopa injection warnings|WARNINGS]]).
| |
| | |
| - with hypersensitivity to any component of this product, including [[sulfites ]](see [[Methyldopa injection warnings|WARNINGS]]).
| |
| | |
| - on therapy with [[monoamine oxidase]] (MAO) inhibitors.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = METHYLDOPATE HYDROCHLORIDE INJECTION, SOLUTION [AMERICAN REGENT, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f5f25053-a9f3-48b9-a412-078f5ee942fd | publisher = | date = | accessdate = 10 March 2014 }}</ref>
| |
| | |
| | |
| | |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
| | |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |